Genetically Modified Humans: Ethics of Developing CRISPR for Use in People
This activity has been archived and credit is no longer available.
In this presentation, Dr. Janet Malek discusses the different ethical considerations that are relevant to implementing CRISPR technology for medical therapy and human enhancement.
This Bioethics Grand Rounds session took place on Wednesday, June 8, 2022 at 12:00 p.m. and has been approved for Ethics Credit and Social Work Credit.
Activity Information
This activity has been archived and credit is no longer available.
Needs Statement
Staff physicians and other allied health professionals need to be regularly updated on the guidelines and challenges related to ethics consultation, clinical ethics practice and the role of ethics in shared clinical decision-making. The series aims to increase knowledge of the learners in these topic areas, and to provide the skills and tools for their implementation in clinical practice in order to enhance the quality of patient care.
Educational Objectives
At the conclusion of the session, the participants should be able to:
- Describe how the gene editing tool, CRISPR, can be used in humans for therapy and enhancement.
- Identify the ethical considerations that are relevant to decisions about developing CRISPR in humans and policies about its use.
- Analyze emerging questions regarding the use of CRISPR in humans using relevant ethical considerations.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
Interest Groups
- Ethics
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been designated by Baylor College of Medicine for 1 credit of education in medical ethics and/or professional responsibility.
Social Work: Baylor College of Medicine, Division of Continuing Professional Development (License Number 7270) is an approved continuing education provider for Social Workers through the Texas State Board of Social Worker Examiners. This activity has been approved for 1 continuing education unit.
Nursing: Texas Children’s Hospital is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This Nursing Continuing Professional Development activity awards 1.0 contact-hours per session.
Activity Director
Term of Approval
June 1, 2022 through June 30, 2024. Original release date: June 1, 2022.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Janet Malek Weinstein, Ph.D.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Activity Director
-
Savitri Fedson, M.D., M.A.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
-
Andrew Childress, Ph.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Savitri Fedson, M.D., M.A.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
David Garvis, Ph.D.
Clinical Ethicist
Baylor St. Luke’s Medical Center
Disclosure:
Nothing to disclose.
-
Claire Horner, J.D., M.A.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: